4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014861
EVP & Chief Commercial Officer sold 11,239 shares at $3.03 ($34,045)
- EVP & Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cheng Sohanya Roshan · EVP & Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-28 | Grant or award : show line 1 in the form | +100,000 | 221,926 | D | ||
| 2023-03-01 | Sale : show line 2 in the form | −11,239 | $3.03 | $34,045 | 210,687 | D |
| Open-market sales · 11,239 sh · avg $3.03 · $34,045 | ||||||
Loading xslF345X03/doc4.xml…